+987.9%
MRNA vs LCID
-79.4%
+1,067.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LCID | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +11.6% | +1.5% | +9.0% |
| 7D | +20.6% | -1.2% | +21.8% | +20.9% |
| 30D | +27.1% | -19.2% | +46.3% | +35.7% |
| 3M | +353.4% | -56.7% | +410.1% | +486.6% |
| 6M | +446.3% | -49.6% | +495.9% | +557.4% |
| YTD | +776.2% | -68.1% | +844.3% | +1,137.8% |
| 1Y | +987.9% | -79.4% | +1,067.3% | +1,784.7% |
| All | +987.9% | -79.4% | +1,067.3% | +1,784.7% |
Cumulative growth
Daily Returns
Daily percentage return beside LCID.
Daily Out/Under-Performance
Portfolio return minus LCID return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LCID return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LCID wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling